Cargando…

RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5

Lung cancers are the leading cause of cancer-related deaths worldwide, with small cell lung cancer (SCLC) being the most aggressive type. At the time of diagnosis, SCLC has usually already metastasized, and an astonishing 95% of patients eventually succumb to the disease. This highlights the need fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Loiselle, Julie J., Roy, Justin G., Sutherland, Leslie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491171/
https://www.ncbi.nlm.nih.gov/pubmed/28662214
http://dx.doi.org/10.1371/journal.pone.0180258
_version_ 1783247097159483392
author Loiselle, Julie J.
Roy, Justin G.
Sutherland, Leslie C.
author_facet Loiselle, Julie J.
Roy, Justin G.
Sutherland, Leslie C.
author_sort Loiselle, Julie J.
collection PubMed
description Lung cancers are the leading cause of cancer-related deaths worldwide, with small cell lung cancer (SCLC) being the most aggressive type. At the time of diagnosis, SCLC has usually already metastasized, and an astonishing 95% of patients eventually succumb to the disease. This highlights the need for more effective SCLC screening and treatment options. Interestingly, the earliest and most frequent genetic alteration associated with lung cancers involves a lesion in the region to which the RNA binding protein RBM5 maps. We have recently shown that a decrease in RBM5 expression may be a key step in SCLC development, as RBM5 regulated many transformation-associated processes in SCLC cells. RBM5 is structurally and functionally similar to another RNA binding protein, RBM10. Both proteins have tumor-suppressor properties in a variety of cancer cell lines, and it has been suggested that RBM5 expression can influence RBM10. Due to their similarities, and the recent evidence that RBM10 is mutated in up to 21% of lung cancers, we hypothesized that RBM10 would share RBM5’s tumor-suppressor properties in SCLC. Using transcriptome analysis and functional assays, we show, however, that RBM10’s function was opposite to what we hypothesized; in the endogenously RBM5-null GLC20 SCLC cell line, RBM10 actually promoted cell proliferation and other transformation-associated processes. Using RNA immunoprecipitation followed by next generation sequencing (RIP-Seq) and Western blotting, we demonstrate that RBM5 post-transcriptionally regulated RBM10 expression via direct interaction with specific RBM10 splice variants. We propose a working model describing the impact of this interaction on cellular processes. Our results provide evidence that RBM10 expression, in RBM5-null tumors, may contribute to tumor growth and metastasis. Measurement of both RBM10 and RBM5 expression in clinical samples may therefore hold prognostic and/or potentially predictive value.
format Online
Article
Text
id pubmed-5491171
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54911712017-07-18 RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5 Loiselle, Julie J. Roy, Justin G. Sutherland, Leslie C. PLoS One Research Article Lung cancers are the leading cause of cancer-related deaths worldwide, with small cell lung cancer (SCLC) being the most aggressive type. At the time of diagnosis, SCLC has usually already metastasized, and an astonishing 95% of patients eventually succumb to the disease. This highlights the need for more effective SCLC screening and treatment options. Interestingly, the earliest and most frequent genetic alteration associated with lung cancers involves a lesion in the region to which the RNA binding protein RBM5 maps. We have recently shown that a decrease in RBM5 expression may be a key step in SCLC development, as RBM5 regulated many transformation-associated processes in SCLC cells. RBM5 is structurally and functionally similar to another RNA binding protein, RBM10. Both proteins have tumor-suppressor properties in a variety of cancer cell lines, and it has been suggested that RBM5 expression can influence RBM10. Due to their similarities, and the recent evidence that RBM10 is mutated in up to 21% of lung cancers, we hypothesized that RBM10 would share RBM5’s tumor-suppressor properties in SCLC. Using transcriptome analysis and functional assays, we show, however, that RBM10’s function was opposite to what we hypothesized; in the endogenously RBM5-null GLC20 SCLC cell line, RBM10 actually promoted cell proliferation and other transformation-associated processes. Using RNA immunoprecipitation followed by next generation sequencing (RIP-Seq) and Western blotting, we demonstrate that RBM5 post-transcriptionally regulated RBM10 expression via direct interaction with specific RBM10 splice variants. We propose a working model describing the impact of this interaction on cellular processes. Our results provide evidence that RBM10 expression, in RBM5-null tumors, may contribute to tumor growth and metastasis. Measurement of both RBM10 and RBM5 expression in clinical samples may therefore hold prognostic and/or potentially predictive value. Public Library of Science 2017-06-29 /pmc/articles/PMC5491171/ /pubmed/28662214 http://dx.doi.org/10.1371/journal.pone.0180258 Text en © 2017 Loiselle et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Loiselle, Julie J.
Roy, Justin G.
Sutherland, Leslie C.
RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5
title RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5
title_full RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5
title_fullStr RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5
title_full_unstemmed RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5
title_short RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5
title_sort rbm10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by rbm5
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491171/
https://www.ncbi.nlm.nih.gov/pubmed/28662214
http://dx.doi.org/10.1371/journal.pone.0180258
work_keys_str_mv AT loisellejuliej rbm10promotestransformationassociatedprocessesinsmallcelllungcancerandisdirectlyregulatedbyrbm5
AT royjusting rbm10promotestransformationassociatedprocessesinsmallcelllungcancerandisdirectlyregulatedbyrbm5
AT sutherlandlesliec rbm10promotestransformationassociatedprocessesinsmallcelllungcancerandisdirectlyregulatedbyrbm5